当前位置: X-MOL 学术Adv. Mater. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Is 3D Printing of Pharmaceuticals a Disruptor or Enabler?
Advanced Materials ( IF 27.4 ) Pub Date : 2018-12-03 , DOI: 10.1002/adma.201805680
Kun Liang 1 , Davide Brambilla 2 , Jean-Christophe Leroux 3
Affiliation  

Additive manufacturing (AM) is a fast‐growing manufacturing approach that comes with the promise of delivering personalized medicine to treat individual patients. However, large‐scale commercial applications in the pharmaceutical industry have been limited. Here, some of the challenges are discussed along with some pharmaceutical products where AM has the potential to make a tangible impact and pave the way for more rapid adoption are highlighted.

中文翻译:

药品的3D打印是破坏者还是推动者?

增材制造(AM)是一种快速发展的制造方法,有望提供个性化药物来治疗各个患者。但是,在制药工业中的大规模商业应用受到限制。在此,我们将讨论一些挑战以及一些药品,其中AM可能会产生切实的影响并为更快速的采用铺平道路。
更新日期:2018-12-03
down
wechat
bug